PhRMA CEO Steve Ubl discusses, PBM reform, the "pill penalty" with the administration and advocating for pharmaceutical ...
As the second Trump administration settles in, the U.S.' top pharmaceutical trade group is drafting its ambitions for the ...
The meeting, which will include Pfizer CEO Albert Bourla as the newly named board of directors’ chair, will reportedly cover ...
The Trump administration, perhaps surprisingly, chose to defend the legality of the Inflation Reduction Act’s (IRA’s) drug ...
The FDA determined that Novo Nordisk’s obesity and diabetes drugs are no longer in short supply. Elsewhere, Concentra made a ...
A new report from industry trade group the Pharmaceutical Research and Manufacturers of America (PhRMA) has shed a new light ...
The PhRMA Foundation announced the appointment to its Board of Directors of Dr. John C. Reed, MD, PhD, Executive Vice President of Innovative Medicine R&D at Johnson & Johnson (J&J), and Dr. Donatello ...
As Republicans gear up to pass the first major tax bill since the 2017 Tax Cuts and Jobs Act, Citibank hired Ernst & Young ...
President Donald Trump has warned a group of major U.S. drugmakers that his administration is set to impose tariffs on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback